MRNA Live signaler | Maksimer profitt med Getagraph.com

SELG 2009 min ago

@ $123.03

Utstedt: 3 mai 2024 @ 20:10

Avkastning: 1.60%

Forrige signal: mai 2 - 21:25

Forrige signal: Kjøp

Avkastning: -2.79 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	4.45M
Gjennomsnittsvolum	3.92M
Markedsverdi	47.86B
EPS	$0.550 ( 2024-05-02 )
Neste inntjeningsdato	( $-3.58 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.01
ATR14	$4.36 (3.49%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Afeyan Noubar	Sell	3 982	Common Stock
2024-05-01	Afeyan Noubar	Sell	4 572	Common Stock
2024-05-01	Afeyan Noubar	Sell	4 246	Common Stock
2024-05-01	Afeyan Noubar	Sell	1 500	Common Stock
2024-05-01	Afeyan Noubar	Sell	700	Common Stock

INSIDER POWER
28.77
Last 100 transactions
Buy: 522 719 \| Sell: 285 992

Volum Korrelasjon

Lang: 0.92 (very strong)

Kort: -0.70 (moderate negative)

Signal:(54) Neutral

Moderna Inc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner
RMRM	-0.925

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Moderna Inc Korrelasjon - Valuta/Råvare

0.45
( neutral )

0.82
( strong )

0.00
( neutral )

0.30
( neutral )

-0.32
( neutral )

-0.82
( strong negative )

Moderna Inc Økonomi

Annual	2023
Omsetning:	$6.75B
Bruttogevinst:	$2.06B (30.52 %)
EPS:	$-12.34

FY	2023
Omsetning:	$6.75B
Bruttogevinst:	$2.06B (30.52 %)
EPS:	$-12.34

FY	2022
Omsetning:	$19.26B
Bruttogevinst:	$13.85B (71.88 %)
EPS:	$21.22

FY	2021
Omsetning:	$18.47B
Bruttogevinst:	$15.85B (85.83 %)
EPS:	$30.31

Financial Reports:

No articles found.

Moderna Inc

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.